Merck (MRK) Form 144: Proposed sale of 7,085 shares

Merck & Co., Inc. (MRK) reported a Form 144 notice for a proposed sale of up to 7,085 shares of common stock, with an aggregate market value of $616,395.00.

Accepted by SEC EDGAR 11/10/2025 - 04:07 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Merck & Co., Inc. (MRK) reported a Form 144 notice for a proposed sale of up to 7,085 shares of common stock, with an aggregate market value of $616,395.00. The planned sale is listed for the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services, with an approximate sale date of November 10, 2025.

The shares to be sold were acquired via restricted stock vesting under a registered plan in two tranches: 2,361 shares on 01/17/2025 and 4,724 shares on 01/27/2025. Shares outstanding are shown as 2,482,022,536, which is a baseline figure and not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Merck (MRK) disclose in the Form 144?

A proposed sale of up to 7,085 Merck common shares with an aggregate market value of $616,395.00.

When is the proposed sale date for MRK shares under Form 144?

The approximate sale date is November 10, 2025.

How were the MRK shares to be sold acquired?

Through restricted stock vesting under a registered plan on 01/17/2025 (2,361 shares) and 01/27/2025 (4,724 shares).

Which broker and exchange are listed for the MRK Form 144 sale?

Broker: Morgan Stanley Smith Barney LLC Executive Financial Services; Exchange: NYSE.

How many Merck shares are outstanding according to the notice?

The notice lists 2,482,022,536 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001879216
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MERCK & CO. INC.
SEC File Number	001-06571
Address of Issuer	126 East Lincoln Avenue Rahway NEW JERSEY 07065
Phone	(732) 594-4000
Name of Person for Whose Account the Securities are To Be Sold	CRISTAL DOWNING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7085	616395.00	2482022536	11/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/17/2025	Restricted stock vesting under a registered plan	Issuer			2361	01/17/2025	Not Applicable
Common	01/27/2025	Restricted stock vesting under a registered plan	Issuer			4724	01/27/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Cristal Downing
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)